FS
Finley Sara Director
Board F
US US · SEC (Form 4)
€86,193
▲ Purchases (2 ops.)
Explore the full record of transactions filed by Finley Sara, Director. Insider active across 2 companies, notably Tivity Health, INC.. In total, 19 filings have been logged. Total volume traded: €86k. The latest transaction was disclosed on 23 May 2022 — Don. Regulator: SEC (Form 4). All data is openly available.
Declarations 19 total
027,681 shares 0
Common Stock
SEC:0001567619-22-013488:0 · 23 May 2022
08,778 shares 0
Common Stock, par value $0.01
SEC:0001415889-22-006888:0 · 19 May 2022
0661 shares 0
Common Stock
SEC:0001567619-22-007830:0 · 31 Mar 2022
0804 shares 0
Common Stock
SEC:0001567619-22-000317 · 31 Dec 2021
0804 shares 0
Common Stock
SEC:0001567619-22-000317:0 · 31 Dec 2021
05,048 shares 0
Common Stock
SEC:0001567619-21-017811 · 20 May 2021
€18,369 922 shares @ €19.9231 100.0% of flow
Common Stock
SEC:0001567619-21-017807 · 30 Sept 2021
0485 shares 0
Common Stock
SEC:0001567619-21-017809 · 30 Jun 2021
€18,369 922 shares @ €19.9231 50.0% of flow
Common Stock
SEC:0001567619-21-017807:0 · 30 Sept 2021
05,048 shares 0
Common Stock
SEC:0001567619-21-017811:0 · 20 May 2021
0485 shares 0
Common Stock
SEC:0001567619-21-017809:0 · 30 Jun 2021
0485 shares 0
Common Stock
SEC:0001567619-21-012845 · 30 Jun 2021
0485 shares 0
Common Stock
SEC:0001567619-21-012845:0 · 30 Jun 2021
€43,096 5,000 shares @ €8.6193 100.0% of flow
Common Stock, par value $0.01
SEC:0001638599-21-000525 · 7 Jun 2021
Ideal exit: 4 Mar 2022 (T+270) €43,096 5,000 shares @ €8.6193 50.0% of flow
Common Stock, par value $0.01
SEC:0001638599-21-000525:0 · 7 Jun 2021
Ideal exit: 4 Mar 2022 (T+270) 07,797 shares 0
Common Stock, par value $0.01
SEC:0001638599-21-000493 · 3 Jun 2021
07,797 shares 0
Common Stock, par value $0.01
SEC:0001638599-21-000493:0 · 3 Jun 2021
05,048 shares 0
Common Stock
SEC:0001567619-21-010871 · 20 May 2021
05,048 shares 0
Common Stock
SEC:0001567619-21-010871:0 · 20 May 2021
About Finley Sara Sara Finley is associated with TIVITY HEALTH, INC.